Liberty Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $456K | Buy |
+5,040
| New | +$422K | 0.08% | 128 |
|
|
2025
Q4 | $430K | Hold |
5,040
| – | – | 0.08% | 126 |
|
|
2025
Q3 | $392K | Hold |
5,040
| – | – | 0.07% | 127 |
|
|
2025
Q2 | $394K | Hold |
5,040
| – | – | 0.08% | 125 |
|
|
2025
Q1 | $365K | Hold |
5,040
| – | – | 0.08% | 123 |
|
|
2024
Q4 | $373K | Hold |
5,040
| – | – | 0.08% | 121 |
|
|
2024
Q3 | $333K | Hold |
5,040
| – | – | 0.07% | 124 |
|
|
2024
Q2 | $466K | Hold |
5,040
| – | – | 0.11% | 113 |
|
|
2024
Q1 | $482K | Hold |
5,040
| – | – | 0.12% | 113 |
|
|
2023
Q4 | $384K | Hold |
5,040
| – | – | 0.1% | 114 |
|
|
2023
Q3 | $349K | Hold |
5,040
| – | – | 0.1% | 114 |
|
|
2023
Q2 | $475K | Hold |
5,040
| – | – | 0.14% | 102 |
|
|
2023
Q1 | $417K | Hold |
5,040
| – | – | 0.14% | 101 |
|
|
2022
Q4 | $376K | Hold |
5,040
| – | – | 0.13% | 106 |
|
|
2022
Q3 | $416K | Hold |
5,040
| – | – | 0.16% | 98 |
|
|
2022
Q2 | $479K | Hold |
5,040
| – | – | 0.17% | 94 |
|
|
2022
Q1 | $593K | Hold |
5,040
| – | – | 0.17% | 94 |
|
|
2021
Q4 | $653K | Hold |
5,040
| – | – | 0.18% | 92 |
|
|
2021
Q3 | $571K | Hold |
5,040
| – | – | 0.17% | 91 |
|
|
2021
Q2 | $522K | Hold |
5,040
| – | – | 0.16% | 93 |
|
|
2021
Q1 | $422K | Hold |
5,040
| – | – | 0.15% | 97 |
|
|
2020
Q4 | $460K | Buy |
+5,040
| New | +$418K | 0.17% | 94 |
|
|
2020
Q2 | $348K | Hold |
5,040
| – | – | 0.15% | 96 |
|
|
2020
Q1 | $317K | Hold |
5,040
| – | – | 0.17% | 92 |
|
|
2019
Q4 | $392K | Hold |
5,040
| – | – | 0.16% | 96 |
|
|
2019
Q3 | $369K | Hold |
5,040
| – | – | 0.16% | 98 |
|
|
2019
Q2 | $310K | Hold |
5,040
| – | – | 0.14% | 109 |
|
|
2019
Q1 | $321K | Hold |
5,040
| – | – | 0.16% | 94 |
|
|
2018
Q4 | $257K | Hold |
5,040
| – | – | 0.16% | 94 |
|
|
2018
Q3 | $292K | Hold |
5,040
| – | – | 0.15% | 92 |
|
|
2018
Q2 | $245K | Hold |
5,040
| – | – | 0.14% | 98 |
|
|
2018
Q1 | $234K | Hold |
5,040
| – | – | 0.14% | 98 |
|
|
2017
Q4 | $203K | Hold |
5,040
| – | – | 0.11% | 113 |
|
|
2017
Q3 | $190K | Hold |
5,040
| – | – | 0.1% | 123 |
|
|
2017
Q2 | $198K | Hold |
5,040
| – | – | 0.12% | 110 |
|
|
2017
Q1 | $158K | Hold |
5,040
| – | – | 0.1% | 120 |
|
|
2016
Q4 | $161K | Sell |
5,040
-2,400
| -32% | -$77.8K | 0.1% | 111 |
|
|
2016
Q3 | $296K | Hold |
7,440
| – | – | 0.19% | 92 |
|
|
2016
Q2 | $247K | Buy |
+7,440
| New | +$255K | 0.17% | 98 |
|
Other funds holding EW
WT
Liberty Capital Management's EW Position: Q2 2026 in Review
Liberty Capital Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 5,040 shares worth $456K. The stake represents 0.08% of the portfolio and ranks #128 among its holdings. This is a return to the name: Liberty Capital Management previously reported a position in EW as recently as Q4 2025.
Liberty Capital Management first reported a position in EW in Q2 2016 and has held it in 39 quarters since. The position peaked at $653K in Q4 2021. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Liberty Capital Management held 5,040 shares of Edwards Lifesciences worth $456K as of Q2 2026.
- Edwards Lifesciences was a new Liberty Capital Management position in Q2 2026.
- Edwards Lifesciences made up 0.08% of Liberty Capital Management's portfolio in Q2 2026, its #128 holding.
- Liberty Capital Management first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 39 quarters since.
- Liberty Capital Management's Edwards Lifesciences position peaked at $653K in Q4 2021.
- 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Liberty Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.